These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25448683)

  • 1. Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication.
    Vito ST; Austin AT; Banks CN; Inceoglu B; Bruun DA; Zolkowska D; Tancredi DJ; Rogawski MA; Hammock BD; Lein PJ
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):185-94. PubMed ID: 25448683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral assessment of NIH Swiss mice acutely intoxicated with tetramethylenedisulfotetramine.
    Flannery BM; Silverman JL; Bruun DA; Puhger KR; McCoy MR; Hammock BD; Crawley JN; Lein PJ
    Neurotoxicol Teratol; 2015; 47():36-45. PubMed ID: 25446016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures.
    Bruun DA; Cao Z; Inceoglu B; Vito ST; Austin AT; Hulsizer S; Hammock BD; Tancredi DJ; Rogawski MA; Pessah IN; Lein PJ
    Neuropharmacology; 2015 Aug; 95():332-42. PubMed ID: 25882826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam.
    Zolkowska D; Dhir A; Rogawski MA
    Arch Toxicol; 2021 Jul; 95(7):2459-2468. PubMed ID: 33914090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined diazepam and MK-801 therapy provides synergistic protection from tetramethylenedisulfotetramine-induced tonic-clonic seizures and lethality in mice.
    Shakarjian MP; Ali MS; Velíšková J; Stanton PK; Heck DE; Velíšek L
    Neurotoxicology; 2015 May; 48():100-8. PubMed ID: 25783504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of γ-aminobutyric acid type A receptor (GABA
    Mundy PC; Pressly B; Carty DR; Yaghoobi B; Wulff H; Lein PJ
    Toxicol Appl Pharmacol; 2021 Sep; 426():115643. PubMed ID: 34265354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of larval zebrafish to the seizurogenic activity of GABA type A receptor antagonists.
    Bandara SB; Carty DR; Singh V; Harvey DJ; Vasylieva N; Pressly B; Wulff H; Lein PJ
    Neurotoxicology; 2020 Jan; 76():220-234. PubMed ID: 31811871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine.
    Zolkowska D; Banks CN; Dhir A; Inceoglu B; Sanborn JR; McCoy MR; Bruun DA; Hammock BD; Lein PJ; Rogawski MA
    J Pharmacol Exp Ther; 2012 May; 341(2):435-46. PubMed ID: 22328574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABA(A) receptors.
    Shakarjian MP; Velíšková J; Stanton PK; Velíšek L
    Toxicol Appl Pharmacol; 2012 Nov; 265(1):113-21. PubMed ID: 23022509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetramethylenedisulfotetramine alters Ca²⁺ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation.
    Cao Z; Hammock BD; McCoy M; Rogawski MA; Lein PJ; Pessah IN
    Toxicol Sci; 2012 Dec; 130(2):362-72. PubMed ID: 22889812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy.
    Hung YW; Hung SW; Wu YC; Wong LK; Lai MT; Shih YH; Lee TS; Lin YY
    Brain Behav Immun; 2015 Jan; 43():118-29. PubMed ID: 25135858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus.
    Calsbeek JJ; González EA; Boosalis CA; Zolkowska D; Bruun DA; Rowland DJ; Saito NH; Harvey DJ; Chaudhari AJ; Rogawski MA; Garbow JR; Lein PJ
    Neurotoxicology; 2021 Dec; 87():43-50. PubMed ID: 34478772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the toxicokinetics of the convulsants picrotoxinin and tetramethylenedisulfotetramine (TETS) in mice.
    Pressly B; Vasylieva N; Barnych B; Singh V; Singh L; Bruun DA; Hwang SH; Chen YJ; Fettinger JC; Johnnides S; Lein PJ; Yang J; Hammock BD; Wulff H
    Arch Toxicol; 2020 Jun; 94(6):1995-2007. PubMed ID: 32239239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.
    Shen Y; Peng W; Chen Q; Hammock BD; Liu J; Li D; Yang J; Ding J; Wang X
    Brain Behav Immun; 2019 Oct; 81():535-544. PubMed ID: 31306773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage.
    Kadriu B; Guidotti A; Costa E; Auta J
    Toxicology; 2009 Feb; 256(3):164-74. PubMed ID: 19111886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.
    Althurwi HN; Tse MM; Abdelhamid G; Zordoky BN; Hammock BD; El-Kadi AO
    Br J Pharmacol; 2013 Apr; 168(8):1794-807. PubMed ID: 23176298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam.
    Vlainić J; Pericić D
    Neuropharmacology; 2009 Jun; 56(8):1124-30. PubMed ID: 19345234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
    Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
    J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
    Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern.
    Ostermann AI; Herbers J; Willenberg I; Chen R; Hwang SH; Greite R; Morisseau C; Gueler F; Hammock BD; Schebb NH
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):131-7. PubMed ID: 26117215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.